A Phase 1 study of SPY001-001 in healthy volunteers

Completed Phase 1 NCT06448247

Study Description

A study to evaluate the safety, tolerability, and pharmacokinetics of SPY001-001 in healthy participants

Study Details

Registry ID:
NCT06448247
Conditions:
Healthy
Phase:
Phase 1
Target Enrollment:
96 participants
Start Date:
Age Range:
18–65 years
Healthy Volunteers:
No

Study Locations (2 sites)

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.

View full study details and check eligibility →